Back
Rate this talk
Your peers have not rated this talk yet.
4-minute watch | Talk 5 of 8

Prof. Graham Collins: Expert perspective

RTC and QTC collaborations

Prof. Graham Collins
PERSPECTIVE
General

Prof. Graham Collins
Oxford University Hospitals, Oxford, UK

Prof. Graham Collins of Oxford University Hospitals, Oxford, UK provides his perspective on RTC and QTC collaborations

Read more

Talks in this series

Dr Graham Collins presents an expert perspective (Early referral for CAR T)
1-minute watch | Talk 1 of 8
Prof. Graham Collins: Expert perspective
Early referral
Dr Graham Collins presents an expert perspective (Early referral for CAR T)
1-minute watch
Prof. Graham Collins: Expert perspective

Early referral

Dr Graham Collins presents an expert perspective (Eligibility for CAR T)
3-minute watch | Talk 2 of 8
Eligibility for CAR T
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Eligibility for CAR T)
3-minute watch

Eligibility for CAR T

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Referral for CAR T)
1-minute watch | Talk 3 of 8
Referral considerations
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Referral for CAR T)
1-minute watch

Referral considerations

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (RTC and QTC relationships)
4-minute watch | Talk 4 of 8
RTC and QTC relationships
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (RTC and QTC relationships)
4-minute watch

RTC and QTC relationships

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (RTC and QTC collaborations)
4-minute watch | Talk 5 of 8
RTC and QTC collaborations
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (RTC and QTC collaborations)
4-minute watch

RTC and QTC collaborations

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Handover post CAR T infusion)
4-minute watch | Talk 6 of 8
Post CAR T handover
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Handover post CAR T infusion)
4-minute watch

Post CAR T handover

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Prepare patients for CAR T)
5-minute watch | Talk 7 of 8
Preparing the patient for CAR T
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Prepare patients for CAR T)
5-minute watch

Preparing the patient for CAR T

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (The centre of qualification process with Kite)
3-minute watch | Talk 8 of 8
Centre qualification process
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (The centre of qualification process with Kite)
3-minute watch

Centre qualification process

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Early referral for CAR T)
1-minute watch | Talk 1 of 8
Prof. Graham Collins: Expert perspective
Early referral
Dr Graham Collins presents an expert perspective (Early referral for CAR T)
1-minute watch
Prof. Graham Collins: Expert perspective

Early referral

Dr Graham Collins presents an expert perspective (Eligibility for CAR T)
3-minute watch | Talk 2 of 8
Eligibility for CAR T
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Eligibility for CAR T)
3-minute watch

Eligibility for CAR T

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Referral for CAR T)
1-minute watch | Talk 3 of 8
Referral considerations
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Referral for CAR T)
1-minute watch

Referral considerations

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (RTC and QTC relationships)
4-minute watch | Talk 4 of 8
RTC and QTC relationships
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (RTC and QTC relationships)
4-minute watch

RTC and QTC relationships

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (RTC and QTC collaborations)
4-minute watch | Talk 5 of 8
RTC and QTC collaborations
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (RTC and QTC collaborations)
4-minute watch

RTC and QTC collaborations

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Handover post CAR T infusion)
4-minute watch | Talk 6 of 8
Post CAR T handover
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Handover post CAR T infusion)
4-minute watch

Post CAR T handover

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (Prepare patients for CAR T)
5-minute watch | Talk 7 of 8
Preparing the patient for CAR T
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (Prepare patients for CAR T)
5-minute watch

Preparing the patient for CAR T

Prof. Graham Collins

Dr Graham Collins presents an expert perspective (The centre of qualification process with Kite)
3-minute watch | Talk 8 of 8
Centre qualification process
Prof. Graham Collins
Dr Graham Collins presents an expert perspective (The centre of qualification process with Kite)
3-minute watch

Centre qualification process

Prof. Graham Collins

Interested in this topic?

Find more like this

Suggested for you

Explore suggested content tailored to your role within the CAR T-cell therapy journey

Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.